Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.55 |
| ▸ | UGT2B7 | P16662 | 16/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18050900 | 0.80 | PTPN1 (0.51) | PTPN1UGT2B7NR1H4 | |
| SCHEMBL9975951 | 0.80 | UGT2B7 (0.41) | PTPN1UGT2B7 | |
| SCHEMBL23284065 | 0.75 | PTPN1 (0.62) | PTPN1UGT2B7NR1H4ALDH1A1CYP3A4 | |
| SCHEMBL160601 | 0.71 | PTPN1 (1.00) | PTPN1NR1H4ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL8068676 | 0.71 | PTPN1 (1.00) | PTPN1NR1H4ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL4453645 | 0.70 | PTPN1 (0.41) | PTPN1UGT2B7 | |
| SCHEMBL29397485 | 0.68 | PTPN1 (0.44) | PTPN1UGT2B7ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL16243482 | 0.66 | UGT2B7 (0.47) | UGT2B7 | |
| SCHEMBL16243483 | 0.66 | UGT2B7 (0.47) | UGT2B7 | |
| SCHEMBL29617465 | 0.66 | UGT2B7 (0.40) | PTPN1UGT2B7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | L'OREAL (FR) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | CUTA, AHR, TYR | PTPN1 3963/4885UGT2B7 2253/4885NR1H4 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.